Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Criteo S.A. stock logo
CRTO
Criteo
$23.81
-0.7%
$27.63
$23.24
$49.93
$1.39B0.51449,389 shs286,016 shs
Enfusion, Inc. stock logo
ENFN
Enfusion
$10.85
+0.5%
$10.85
$7.83
$11.80
$1.40B0.92699,500 shs2.46 million shs
EXFO Inc. stock logo
EXFO
EXFO
$6.25
$6.09
$2.55
$7.24
$358.75M1.37139,918 shs8,460 shs
inTEST Co. stock logo
INTT
inTEST
$7.68
+6.8%
$6.37
$5.24
$11.92
$95.96M1.6260,292 shs38,565 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Criteo S.A. stock logo
CRTO
Criteo
-0.71%-0.42%-6.85%-31.99%-34.77%
Enfusion, Inc. stock logo
ENFN
Enfusion
0.00%0.00%0.00%-2.31%+29.15%
EXFO Inc. stock logo
EXFO
EXFO
0.00%0.00%0.00%0.00%0.00%
inTEST Co. stock logo
INTT
inTEST
+6.82%+9.87%+26.94%+8.78%-18.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Criteo S.A. stock logo
CRTO
Criteo
4.0872 of 5 stars
4.24.00.00.01.82.51.9
Enfusion, Inc. stock logo
ENFN
Enfusion
N/AN/AN/AN/AN/AN/AN/AN/A
EXFO Inc. stock logo
EXFO
EXFO
N/AN/AN/AN/AN/AN/AN/AN/A
inTEST Co. stock logo
INTT
inTEST
3.5759 of 5 stars
3.33.00.00.03.43.31.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Criteo S.A. stock logo
CRTO
Criteo
2.45
Hold$46.7096.14% Upside
Enfusion, Inc. stock logo
ENFN
Enfusion
2.33
Hold$12.2512.91% Upside
EXFO Inc. stock logo
EXFO
EXFO
0.00
N/AN/AN/A
inTEST Co. stock logo
INTT
inTEST
2.67
Moderate Buy$12.0056.25% Upside

Current Analyst Ratings Breakdown

Latest EXFO, INTT, CRTO, and ENFN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2025
Criteo S.A. stock logo
CRTO
Criteo
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$57.00 ➝ $42.00
5/5/2025
Criteo S.A. stock logo
CRTO
Criteo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$39.00 ➝ $27.00
5/5/2025
Criteo S.A. stock logo
CRTO
Criteo
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$40.00 ➝ $36.00
5/5/2025
Criteo S.A. stock logo
CRTO
Criteo
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$60.00 ➝ $49.00
5/5/2025
inTEST Co. stock logo
INTT
inTEST
Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/5/2025
inTEST Co. stock logo
INTT
inTEST
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $8.00
5/1/2025
Criteo S.A. stock logo
CRTO
Criteo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$68.00 ➝ $66.00
4/30/2025
Criteo S.A. stock logo
CRTO
Criteo
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$50.00 ➝ $38.00
4/25/2025
Criteo S.A. stock logo
CRTO
Criteo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight
4/25/2025
Criteo S.A. stock logo
CRTO
Criteo
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform
4/25/2025
Criteo S.A. stock logo
CRTO
Criteo
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $47.00
(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Criteo S.A. stock logo
CRTO
Criteo
$1.93B0.71$4.71 per share5.06$19.59 per share1.22
Enfusion, Inc. stock logo
ENFN
Enfusion
$201.61M6.94$0.14 per share78.75$0.61 per share17.79
EXFO Inc. stock logo
EXFO
EXFO
$265.58M1.35$0.25 per share25.32$3.10 per share2.01
inTEST Co. stock logo
INTT
inTEST
$127.50M0.75$1.34 per share5.75$7.92 per share0.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Criteo S.A. stock logo
CRTO
Criteo
$111.57M$2.469.687.30N/A7.41%18.21%9.01%7/30/2025 (Estimated)
Enfusion, Inc. stock logo
ENFN
Enfusion
$6.03M$0.03271.2977.491.851.70%6.67%4.86%8/4/2025 (Estimated)
EXFO Inc. stock logo
EXFO
EXFO
-$9.54M-$0.03N/A16.43N/A-2.18%2.14%1.27%N/A
inTEST Co. stock logo
INTT
inTEST
$9.34M-$0.0133.3919.20N/A2.33%5.31%3.42%N/A

Latest EXFO, INTT, CRTO, and ENFN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2025Q1 2025
Criteo S.A. stock logo
CRTO
Criteo
$0.77$1.10+$0.33$0.66$259.86 million$451.43 million
5/2/2025Q1
inTEST Co. stock logo
INTT
inTEST
-$0.10-$0.11-$0.01N/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Criteo S.A. stock logo
CRTO
Criteo
N/AN/AN/AN/AN/A
Enfusion, Inc. stock logo
ENFN
Enfusion
N/AN/AN/AN/AN/A
EXFO Inc. stock logo
EXFO
EXFO
N/AN/AN/AN/AN/A
inTEST Co. stock logo
INTT
inTEST
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Criteo S.A. stock logo
CRTO
Criteo
N/A
1.22
1.22
Enfusion, Inc. stock logo
ENFN
Enfusion
N/A
3.62
3.62
EXFO Inc. stock logo
EXFO
EXFO
0.01
1.45
0.95
inTEST Co. stock logo
INTT
inTEST
0.08
2.26
1.38

Institutional Ownership

CompanyInstitutional Ownership
Criteo S.A. stock logo
CRTO
Criteo
94.27%
Enfusion, Inc. stock logo
ENFN
Enfusion
81.05%
EXFO Inc. stock logo
EXFO
EXFO
7.99%
inTEST Co. stock logo
INTT
inTEST
63.18%

Insider Ownership

CompanyInsider Ownership
Criteo S.A. stock logo
CRTO
Criteo
1.66%
Enfusion, Inc. stock logo
ENFN
Enfusion
36.44%
EXFO Inc. stock logo
EXFO
EXFO
20.00%
inTEST Co. stock logo
INTT
inTEST
7.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Criteo S.A. stock logo
CRTO
Criteo
3,50757.85 million56.90 millionOptionable
Enfusion, Inc. stock logo
ENFN
Enfusion
890129.00 million81.72 millionOptionable
EXFO Inc. stock logo
EXFO
EXFO
1,81457.45 millionN/ANot Optionable
inTEST Co. stock logo
INTT
inTEST
32012.50 million11.69 millionOptionable

Recent News About These Companies

inTEST: Battling Market Headwinds
What is Northland Capmk's Forecast for inTEST Q3 Earnings?
inTest Q1 2025 Earnings Preview
InTest Recognized for Excellence by Texas Instruments
Northland Securities Remains a Buy on inTEST (INTT)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Criteo stock logo

Criteo NASDAQ:CRTO

$23.81 -0.17 (-0.71%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$23.90 +0.09 (+0.37%)
As of 06/26/2025 05:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Criteo S.A., a technology company, provides marketing and monetization services on the open Internet in North and South America, Europe, the Middle East, Africa, and the Asia-Pacific. The company's Criteo Shopper Graph, which derives clients' proprietary commerce data, such as transaction activity on their digital properties. It also offers Criteo AI Engine solutions, including lookalike finder, recommendation, and predictive bidding algorithms; recommendation algorithms, dynamic creative optimization+, sponsored product placement algorithms, and other product placement algorithms. The company's technology comprises data synchronization, storage, and analysis of distributed computing infrastructure in various geographies, as well as fast data collection and retrieval using multi-layered caching infrastructure; and experimentation platform, an offline/online testing platform to enhance the capabilities and effectiveness of prediction models. In addition, it provides Criteo Marketing Solutions that allow commerce companies to address various marketing goals by engaging their consumers with personalized ads across the web, mobile, and offline store environments; and Criteo Retail Media solutions, which allows retailers to generate advertising revenues from consumer brands, and/or to drive sales for themselves, by monetizing their data and audiences through personalized ads, either on their own digital property or on the open Internet. Further, the company offers real-time advertising technology and trading infrastructure, delivering advanced media buying, selling, and packaging capabilities for media owners, agencies, performance advertisers, and third-party AdTech platforms. It serves companies in digital retail, travel, and classifieds sectors. Criteo S.A. was incorporated in 2005 and is headquartered in Paris, France.

Enfusion stock logo

Enfusion NYSE:ENFN

$10.85 +0.05 (+0.45%)
Closing price 04/17/2025
Extended Trading
$10.85 0.00 (0.00%)
As of 04/17/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

EXFO stock logo

EXFO NASDAQ:EXFO

EXFO, Inc. engages in the provision of test, monitoring, and analytics solutions for fixed and mobile communications service providers, webscale companies and equipment manufacturers. It offers field network testing, optical benchtop kits, tunable filters, network simulation and load testing, and switch and utility module. The company was founded by Germain Lamonde on September 18, 1985 and is headquartered in Quebec, Canada.

inTEST stock logo

inTEST NYSE:INTT

$7.68 +0.49 (+6.82%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$7.68 0.00 (0.00%)
As of 06/26/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.